Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
Chowell D*, Yoo SK*, Valero C*, et al. Improved prediction of immune checkpoint blockade efficacy across multiple cancer types. Nat Biotechnol. 2021.
Read MoreChowell D*, Yoo SK*, Valero C*, et al. Improved prediction of immune checkpoint blockade efficacy across multiple cancer types. Nat Biotechnol. 2021.
Read MoreLu SX*, De Neef E*, Thomas JD, et al. Pharmacologic modulation of RNA splicing enhances anti-tumor immunity. Cell. 2021;184(15): 4032-4047 e4031.
Read MoreKrishna C, DiNatale RG, Kuo F, et al. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. Cancer Cell. 2021;39(5): 662-677 e666.
Read MoreKrishna C*, Chowell D*, Gonen M, Elhanati Y, Chan TA. Genetic and environmental determinants of human TCR repertoire diversity. Immun Ageing. 2020;17:26.
Read MoreChowell D*, Krishna C*, Pierini F*, et al. Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy. Nat Med. 2019;25(11): 1715-1720.
Read MoreYang W*, Lee KW*, Srivastava RM*, et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med. 2019;25(5): 767-775.
Read MoreHavel JJ*, Chowell D*, Chan TA. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer. 2019;19(3): 133-150.
Read MoreChowell D, Morris LGT, Grigg CM, et al. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Science. 2018;359(6375): 582-587.
Read MoreRiaz N*, Havel JJ*, Makarov V*, et al. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell. 2017;171(4): 934-949 e915.
Read MoreChowell D, Napier J, Gupta R, Anderson KS, Maley CC, Sayres MAW. Modeling the Subclonal Evolution of Cancer Cell Populations. Cancer Res. 2018;78(3): 830-839.
Read MoreDahlstrom KR*, Anderson KS*, Field MS, et al. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer. Cancer. 2017;123(24): 4886-4894.
Read MoreChowell D, Boddy AM, Mallo D, Tollis M, Maley CC. When (distant) relatives stay too long: implications for cancer medicine. Genome Biology. 2016;17.
Read MoreDahlstrom KR, Anderson KS, Cheng JN, et al. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx. Clinical Cancer Research. 2015;21(12): 2861-2869.
Read MoreChowell D, Castillo-Chavez C, Krishna S, Qiu X, Anderson KS. Modelling the effect of early detection of Ebola. Lancet Infect Dis. 2015;15(2): 148-149.
Read MoreChowell D*, Krishna S*, Becker PD, et al. TCR contact residue hydrophobicity is a hallmark of immunogenic CD8(+) T cell epitopes. Proceedings of the National Academy of Sciences of the United States of America. 2015;112(14):E1754-E1762.
Read More